Tetra Pharm Technologies Advances CB1 Antagonist TPT0701 for Appetite Suppression into Preclinical Testing
Following the successful filing of the Intellectual Property (IP) for its applied platform technology targeting the endocannabinoid system (ECS), Tetra Pharm Technologies is moving forward with its appetite suppression supplement, TPT0701. Modulation of the endocannabinoid system has long been recognized…
38 Year old man runs his first marathon after 40 kg weight loss after bariatric Surgery
A team headed by Dr Kedar Patil, Bariatric, Hernia and Advanced Laparoscopic Surgeon helps a 38-year-old man to slim down from 180 to 140 kgs in 4 months duration The patient who successfully underwent Laparoscopic Mini Gastric Bypass Surgery, even…
